At Metrolabs, we recognise that the integrity of a controlled environment begins from the ground up. Our structural solutions are engineered to meet the rigorous demands of research, healthcare, and pharmaceutical sectors — creating surfaces that are durable, biologically safe, and compliant with global sterility standards.
Building a laboratory or microbiology unit requires more than standard construction — it requires a deep understanding of contamination control, regulatory compliance, and long-term performance. The floor, the wall-floor junction, and the wet zone surfaces are the three structural elements most commonly responsible for cleanroom qualification failures, and they are the three areas where Metrolabs’ civil and structural expertise delivers the greatest value.
In a pharmaceutical or microbiology cleanroom, the floor is not a passive substrate — it is an active contamination control surface. Every micro-crack in a standard concrete or tiled floor creates a channel where moisture, cleaning agent residue, and micro-organisms accumulate between cleaning cycles and resist standard wipe-down disinfection. When the floor-cleaning mop passes over the crack, it contacts the surrounding surface but cannot penetrate the crack to remove the contamination at its base — so each cleaning cycle redistributes particles from the crack to the surrounding surface rather than removing them.
The seamless epoxy floor eliminates this failure mode by sealing the entire floor area into a single, continuous, non-porous surface with no joints, no cracks, and no expansion gaps. Every point on the floor surface is equally accessible to the cleaning cloth, and every cleaning cycle removes the entire surface contamination load rather than redistributing it from cracks to the surrounding area.
Pharmaceutical-grade epoxy systems achieve a surface porosity of effectively zero — the epoxy matrix is a cross-linked thermoset polymer with no capillary pathways for liquid absorption. Disinfectants applied during cleaning contact the full surface without being absorbed into the floor, ensuring the active concentration reaches every micro-organism on the surface without dilution by absorption into the substrate.
Grade-A chemical resistant epoxy formulations withstand the full pharmaceutical disinfectant range: IPA at 70%, QAC solutions, PAA at 0.5%, sodium hypochlorite at standard disinfection concentrations, and VHP at 1000 ppm — without surface degradation, delamination, or colour change over the full service life of the cleanroom.
Anti-static epoxy formulations incorporate conductive elements that dissipate static charge accumulation from the floor surface to earth — preventing the electrostatic discharge events that can damage sensitive electronic components and create ignition risks in solvent-handling and flammable material areas of pharmaceutical and semiconductor cleanrooms.
The floor-to-wall junction in a standard construction has a 90-degree right-angle intersection — a permanent particle, moisture, and biofilm accumulation zone. The GMP coving skirting installed by Metrolabs creates a continuous curved transition from the floor surface to the wall surface — eliminating the right-angle vertex entirely and making the junction as accessible to the cleaning cloth as the flat floor and wall surfaces on either side of it.
A comprehensive suite of surface treatments engineered for high-traffic, sterile pharmaceutical, biotech, and research environments:
Anti-bacterial, anti-static, seamless epoxy floor systems — the GMP-compliant floor substrate for ISO-classified cleanrooms, pharmaceutical manufacturing suites, hospital operating theatres, and microbiology laboratories.
To maintain a true “clean” environment, the junction between the floor and the wall must be curved. Metrolabs installs high-quality epoxy or PVC coving that creates a smooth, easy-to-clean curved transition — the single most critical GMP junction detail in cleanroom construction.
Safety is paramount in wet zones and wash areas. Metrolabs anti-slip coatings provide necessary traction without compromising the sterile, non-porous nature of the floor — ensuring a secure workspace for personnel in high-splash and high-traffic cleanroom entry points.
Understanding what makes pharmaceutical-grade civil works different from standard industrial flooring:
Pharmaceutical-grade epoxy flooring is a three-component system — a primer coat, a build coat, and a topcoat — applied in sequence over a prepared concrete substrate to create a total system thickness of typically 3–6mm with zero porosity, zero joints, and a surface finish that is as cleanable at the end of its service life as on the day of application.
The anti-bacterial formulation incorporates a biocide (typically silver-ion or quaternary ammonium compound based) into the epoxy matrix during formulation — not applied as a coating on top of the cured epoxy, but chemically bound into the polymer matrix itself. This means the anti-bacterial activity is intrinsic to the floor material and is not depleted by repeated cleaning cycles that would wash away a topically applied biocide.
The anti-static (ESD) variant incorporates conductive carbon fibres or conductive aggregate into the build coat, creating a three-dimensional conductive matrix through the floor thickness. A copper earth tape is embedded at the floor perimeter during application and connected to the building earth, providing a continuous dissipative path from the floor surface to earth that prevents static charge accumulation on personnel and equipment. The surface resistivity is specified at 10⁵–10⁹ ohms — the range specified by IEC 61340 for electrostatic dissipative (ESD) floors in semiconductor and pharmaceutical manufacturing areas.
Chemical-resistant formulation withstands IPA 70%, QAC, PAA 0.5%, sodium hypochlorite, VHP 1000 ppm over full cleanroom service life.
Three-coat system, 3–6mm total thickness. No capillary pathways — disinfectants reach full active concentration at surface.
Surface resistivity 10⁵–10⁹ ohm per IEC 61340. Copper earth tape at perimeter. Protects electronics and prevents ignition in solvent areas.
No expansion joints, no grout lines, no panel edges — the entire floor area is a single continuous non-porous surface.
The coving skirting at the floor-to-wall junction is the single most frequently cited GMP deficiency in pharmaceutical cleanroom inspection reports — a finding that costs facilities significant remediation time and qualification downtime every inspection cycle. Yet it is also the simplest and most cost-effective GMP compliance investment in the civil works phase of cleanroom construction: the cost of installing coved skirting during initial construction is a fraction of the cost of retrofitting it after panel installation, and the cost of retrofitting it is a fraction of the cost of a failed GMP inspection.
The Metrolabs coving skirting is available in two material systems — monolithic epoxy coving (applied as a liquid that merges chemically with the floor epoxy to create a truly seamless floor-to-wall transition with no joint at all) and prefabricated PVC coving (a moulded curved profile that is bonded to the floor surface and the wall surface with pharmaceutical-grade adhesive). Both systems achieve the same functional result — a continuous curved transition that eliminates the right-angle vertex — but the epoxy coving provides the higher specification for pharmaceutical Grade A/B environments where the absence of any joint is the requirement, while the PVC coving provides faster installation for Grade C/D and hospital environments where a bonded joint is acceptable.
The radius of the coved profile is specified to meet the WHO GMP and EU Annex 1 requirements for cleanroom corners — typically a 35mm or 50mm radius, sufficient for the cleaning cloth to maintain continuous contact with the surface through the entire curve without lifting off the surface at the junction point.
Monolithic — merges with floor epoxy. Truly seamless — no bonded joint. Grade A/B pharmaceutical standard.
Prefabricated curved profile. Pharmaceutical-grade adhesive bond. Faster installation for Grade C/D and hospital environments.
35mm or 50mm radius — WHO GMP and EU Annex 1 compliant. Cleaning cloth maintains full contact through curve.
Both epoxy and PVC coving systems rated for VHP decontamination at 1000 ppm — no delamination or colour change.
The anti-slip epoxy coating addresses a specific challenge in pharmaceutical cleanroom design: the gowning room, the handwashing station area, and the buffer corridor between the gowning room and the cleanroom entry airlock are all locations where liquid — water from handwashing, IPA from surface disinfection spraying, and disinfectant solution from wet-mop floor cleaning — regularly contacts the floor surface. A standard smooth epoxy floor is extremely slippery when wet, particularly when contaminated with IPA — a low-viscosity, low-surface-tension solvent that reduces the coefficient of friction between shoe soles and the floor surface significantly more than water alone.
The anti-slip epoxy coating incorporates calibrated aluminium oxide (Al₂O₃) aggregate particles into the surface of the final epoxy topcoat — the aggregate is broadcast into the wet epoxy topcoat before curing, and the excess is removed after curing, leaving aggregate particles embedded in the topcoat with their upper surfaces exposed at the floor surface. The exposed aggregate surfaces provide mechanical traction points that prevent shoe sole slip regardless of the liquid on the floor surface. The aggregate particle size and the broadcast density are calibrated to achieve the specified R-value (slip resistance rating per DIN 51130) for the application: R9 for light wet zone exposure, R10 for standard gowning area exposure, R11 for heavy wet zone and wash-down area exposure.
Aluminium oxide broadcast aggregate — calibrated particle size — embedded in topcoat surface. Mechanical traction — no surface film to wear off.
Slip resistance per DIN 51130 — R9 light wet, R10 standard gowning, R11 heavy wet zone. Specified to application requirement.
Anti-slip texture without creating particle-harbouring cavities — aggregate gaps sealed with epoxy overcoat to maintain zero-porosity specification.
Aggregate profile cleanable with standard pharmaceutical disinfectants — mop head contacts aggregate peak surfaces — IPA/QAC penetrate to aggregate base.
Every Metrolabs civil and structural works installation is delivered to this standard — and every parameter impacts cleanroom qualification, compliance, and operational performance:
| Feature | Metrolabs Standard | Impact on Operations |
|---|---|---|
| Material Quality | Grade-A Chemical Resistant Epoxy — pharmaceutical formulation | Resists degradation from harsh disinfectants — full GMP disinfectant range |
| Surface Integrity | Zero-Porosity seamless finish — no joints, no cracks, no grout lines | Ensures 100% sterile surface during wash-downs — no harbour points |
| Anti-Bacterial | Biocide incorporated into polymer matrix — intrinsic, not topical | Inhibits pathogen growth — activity not depleted by cleaning cycles |
| Anti-Static (ESD) | Surface resistivity 10⁵–10⁹ ohm per IEC 61340 | Protects sensitive electronics · Prevents ignition in solvent areas |
| Safety Compliance | Anti-slip aggregate — R9/R10/R11 DIN 51130 per application | Protects personnel in wet zones — no slip risk with IPA or water on floor |
| GMP Coving | Epoxy or PVC — R35/R50 radius — WHO GMP / EU Annex 1 compliant | Eliminates particle/biofilm accumulation zone at floor-wall junction |
| Design Approach | Custom-built for your workflow, ISO class, and process areas | Minimises downtime · Reduces maintenance costs · Compliance from day one |
| VHP Compatibility | All systems rated for VHP 1000 ppm room-wide decontamination | No floor protection required during VHP cycles — immediate return to service |
GMP-compliant epoxy floors, coving skirting, and anti-slip coatings for pharmaceutical manufacturing, hospitals, research, and semiconductor environments:
Grade A/B/C/D cleanroom floors and coving skirting. Anti-bacterial, ESD, and VHP-compatible. WHO GMP, EU Annex 1, Schedule M, 21 CFR compliant.
Operating theatre floors, CSSD floors, ICU corridor flooring. Anti-bacterial seamless epoxy. Coved skirting at all junctions. NABH compliant. Slip-resistant wet zones.
Microbiology lab floors, biosafety level area flooring, NABL lab surfaces. Chemical-resistant seamless finish. Coved transitions for BSL-1/2 containment compliance.
ESD anti-static floors for wafer fabrication, cleanroom assembly areas, and PCB rework zones. Surface resistivity per IEC 61340. Copper earth tape bonding.
FSSAI high-care zone floors. Anti-bacterial, non-slip (R11), heavy-duty epoxy for high-wash-down food production areas. HACCP-compliant floor system design.
Chemical-resistant seamless floors for analytical chemistry and quality control laboratories. Anti-slip in wet wash areas. VHP compatible for periodic room decontamination.
ISO 13485 cleanroom floor systems. Anti-bacterial, ESD-controlled, seamless epoxy for device assembly and sterile packaging areas. Zero-porosity for sterility compliance.
Temperature-stable epoxy floors for cold storage areas (-20°C to +25°C). Seamless, anti-bacterial, coved for vaccine and biologic storage and dispensing areas.
Building a laboratory or microbiology unit requires more than just standard construction expertise — it requires a deep understanding of GMP compliance, contamination control, and long-term performance:
Standard industrial epoxy floor systems use lower-grade chemical-resistant formulations that are adequate for warehouses and workshops but degrade progressively under the repeated pharmaceutical disinfectant cycles of a GMP cleanroom. Metrolabs specifies pharmaceutical-grade epoxy formulations that maintain their zero-porosity, anti-bacterial, and chemical-resistant performance throughout the full designed service life of the cleanroom.
Civil works failures in pharmaceutical cleanrooms are most commonly caused by civil contractors working in isolation from the panel and equipment contractors — the floor contractor finishes the floor before the panel installation, and the panel contractor cuts and breaks the floor surface during panel base installation. Metrolabs coordinates the civil works as part of the complete cleanroom installation — the floor system is applied after panel base installation, ensuring the seamless floor surface is continuous to the panel faces and all junctions are properly coved.
Metrolabs’ cleanroom civil works installation team travels to site from Chennai to apply all three floor systems across all Indian states. The application team is trained in pharmaceutical GMP floor installation — including substrate preparation standards (shot blasting, moisture vapour emission testing, crack repair to pharmaceutical specification), application conditions (temperature and humidity monitoring during application), and quality verification (holiday detection testing of the completed floor surface).
Metrolabs civil and structural works are always delivered as part of the complete cleanroom solution — coordinated with wall and partition systems, HVAC installation, cleanroom furniture, air control systems, and microbiology equipment. The civil works are the foundation that every subsequent system is installed on, and they must meet the dimensional, structural, and surface quality requirements of every subsequent phase of the cleanroom installation.
4, SIDCO-MICRO, Thirumudivakkam,
Chennai – 600 132, Tamil Nadu
🗺 Open in Google Maps ↗
www.metrolabs.biz
www.schoollabfurniture.com
GSTN: 33AASFM3382K1ZT
Contact Metrolabs for a free civil works assessment. Our specialists will review your ISO class, facility layout, process area wet zones, and compliance requirements — then specify the right epoxy system, coving profile, and anti-slip configuration for your controlled environment.
Our civil works team will contact you within 24 working hours.
Immediate: 9840931231